Dihydrogalanthamine Hydrobromide

氢溴酸二氢加兰他敏

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDihydrogalanthamine Hydrobromide
Drug Alias Name氢溴酸二氢加兰特敏
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitors
TargetsAcetylcholinesterase
Therapy Area/IndicationsSciaticaHemiplegia
Global Approved IndicationsSciaticaHemiplegia
Approved Indications in ChinaSciaticaHemiplegia
Original Approved Country/TerritoryMainland China
Original Approved Date1982/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsSciaticaHemiplegia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia